Target Name Location MI R Value P Value
GPATCH8G patch domain containing 817q21.310.4030.5660
USP34ubiquitin specific peptidase 342p16.1-p150.3910.4720
KANSL1KAT8 regulatory NSL complex subunit 117q21.310.3910.5380
RLFrearranged L-myc fusion1p320.3860.5890
TAF1TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDaXq13.10.3830.5090
C1orf54chromosome 1 open reading frame 541q21.20.381-0.4990
TRAPPC8trafficking protein particle complex 818q12.10.3790.440
TCP11L2t-complex 11, testis-specific-like 212q23.30.3770.4780
GGT5gamma-glutamyltransferase 522q11.230.376-0.5120
RSBN1round spermatid basic protein 11p13.10.3740.4780
BTAF1BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa10q22-q230.3740.470
RAMP3receptor (G protein-coupled) activity modifying protein 37p13-p120.373-0.5630
ZNF292zinc finger protein 2926q150.3710.5640
GPBAR1G protein-coupled bile acid receptor 12q350.365-0.4860
FBXO11F-box protein 112p16.30.3610.5330
LST1leukocyte specific transcript 16p21.30.353-0.4350
GYPCglycophorin C (Gerbich blood group)2q14-q210.353-0.5110
PECAM1platelet/endothelial cell adhesion molecule 117q23.30.352-0.5040
ZNF654zinc finger protein 6543p11.10.3520.4660
CLASP1cytoplasmic linker associated protein 12q14.2-q14.30.3520.3844e-17
SRPK2SRSF protein kinase 27q22-q31.10.3510.4750
LYL1lymphoblastic leukemia associated hematopoiesis regulator 119p13.130.349-0.4720
GIMAP5GTPase, IMAP family member 57q36.10.347-0.510
GIMAP1GTPase, IMAP family member 17q36.10.347-0.5210
P2RY8purinergic receptor P2Y, G-protein coupled, 8Xp22.33 and Yp11.30.339-0.4330
PHF6PHD finger protein 6Xq260.3380.4810
CLEC3BC-type lectin domain family 3, member B3p22-p21.30.331-0.4970
LYVE1lymphatic vessel endothelial hyaluronan receptor 111p15.40.33-0.4040
KLF2Kruppel-like factor 219p13.110.328-0.4670
ICAM3intercellular adhesion molecule 319p13.3-p13.20.325-0.4980
ADCY4adenylate cyclase 414q11.20.324-0.4810
FAM107Afamily with sequence similarity 107, member A3p14.20.319-0.410
RASGRP2RAS guanyl releasing protein 2 (calcium and DAG-regulated)11q130.318-0.490
CD79BCD79b molecule, immunoglobulin-associated beta17q230.317-0.5080
GJA4gap junction protein, alpha 4, 37kDa1p35.10.315-0.5260
CCL19chemokine (C-C motif) ligand 199p130.311-0.4260
ENGendoglin9q34.110.311-0.4760
USHBP1Usher syndrome 1C binding protein 119p13.110.31-0.4460
DHX40DEAH (Asp-Glu-Ala-His) box polypeptide 4017q220.310.4670
OCRLoculocerebrorenal syndrome of LoweXq250.310.4160
APLNRapelin receptor11q12.10.296-0.4510
FCN3ficolin (collagen/fibrinogen domain containing) 31p36.110.296-0.4610
TNXBtenascin XB6p21.30.296-0.440
SOX17SRY (sex determining region Y)-box 178q11.230.295-0.4690
CETPcholesteryl ester transfer protein, plasma16q130.291-0.4470
CUL4Bcullin 4BXq230.290.3920
GADD45Ggrowth arrest and DNA-damage-inducible, gamma9q22.1-q22.20.289-0.2911.1e-09
SNRNP48small nuclear ribonucleoprotein 48kDa (U11/U12)6p24.30.2890.4490
SLC6A10Psolute carrier family 6 (neurotransmitter transporter), member 10, pseudogene16p11.20.2840.3890
PIGAphosphatidylinositol glycan anchor biosynthesis, class AXp22.10.2840.3582.95e-14
LGALS2lectin, galactoside-binding, soluble, 222q13.10.281-0.4340
PTPN5protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)11p15.10.278-0.3870
GNAI2guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 23p21.310.276-0.3462.56e-13
ETAA1Ewing tumor-associated antigen 12p140.2730.4010
PPFIA4protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 41q32.10.2710.5080
YEATS2YEATS domain containing 23q27.30.270.4490
EGLN1egl-9 family hypoxia-inducible factor 11q42.10.2690.4240
ATXN2Lataxin 2-like16p110.2690.3231.1e-11
HK2hexokinase 22p130.2680.3811.71e-16
MXI1MAX interactor 1, dimerization protein10q24-q250.2650.4880
PDK1pyruvate dehydrogenase kinase, isozyme 12q31.10.2590.4250
SERTAD2SERTA domain containing 22p150.2510.2833.05e-09
BNIP3LBCL2/adenovirus E1B 19kDa interacting protein 3-like8p210.250.382.22e-16
NDRG1N-myc downstream regulated 18q240.2490.4240
NIPA1non imprinted in Prader-Willi/Angelman syndrome 115q11.20.2470.3434.61e-13
ADD2adducin 2 (beta)2p13.30.246-0.030.541
AGTangiotensinogen (serpin peptidase inhibitor, clade A, member 8)1q42.20.245-0.3371.1e-12
ZNF280Bzinc finger protein 280B22q11.20.245-0.0330.493
ZNF343zinc finger protein 34320p130.2440.3257.48e-12
P4HA1prolyl 4-hydroxylase, alpha polypeptide I10q22.10.2410.4110
KHSRPKH-type splicing regulatory protein19p13.30.2410.3275.27e-12
SLC6A8solute carrier family 6 (neurotransmitter transporter), member 8Xq280.2220.3666.17e-15
EGLN3egl-9 family hypoxia-inducible factor 314q120.2210.3793.54e-16
OPA3optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)19q13.320.221-0.0580.235
PFKFB46-phosphofructo-2-kinase/fructose-2,6-biphosphatase 43p22-p210.2150.2891.43e-09
ALDOCaldolase C, fructose-bisphosphate17q11.20.2130.3870
ENO2enolase 2 (gamma, neuronal)12p130.2120.3811.69e-16
SLC9A3solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 35p15.30.1960.2721.24e-08